Ahmed Madisch

Summary

Country: Germany

Publications

  1. ncbi Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study
    Károly R Kulich
    AstraZeneca R and D, Medical Science, Molndal, S 431 86, Sweden
    Health Qual Life Outcomes 6:12. 2008
  2. ncbi Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial
    Ahmed Madisch
    Medical Department I, Technical University Hospital, Fetscherstrasse 74, 01307, Dresden, Germany
    Int J Colorectal Dis 22:1445-51. 2007
  3. ncbi Less favorable clinical outcome after diagnostic and interventional double balloon enteroscopy in patients with suspected small-bowel bleeding?
    A Madisch
    Medical Department I, Technical University Hospital, Dresden, Germany
    Endoscopy 40:731-4. 2008
  4. ncbi NOD2/CARD15 gene polymorphisms are not associated with collagenous colitis
    Ahmed Madisch
    Medical Department I, Technical University Hospital, Fetscherstr 74, D 01307 Dresden, Germany
    Int J Colorectal Dis 22:425-8. 2007
  5. ncbi Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial
    A Madisch
    Medical Department I, Technical University Hospital, Dresden, Germany
    Aliment Pharmacol Ther 23:473-9. 2006
  6. ncbi Management of functional dyspepsia: Unsolved problems and new perspectives
    Ahmed Madisch
    Medical Department I, Technical University Hospital, Fetscherstrasse 74, D 01307 Dresden, Germany
    World J Gastroenterol 11:6577-81. 2005
  7. ncbi Investigational treatment options in microscopic colitis
    Ahmed Madisch
    University Hospital, Carl Gustav Carus Dresden, Medical Department I, Fetscherstrasse 74, D 01307 Dresden, Germany
    Expert Opin Investig Drugs 17:1829-37. 2008
  8. ncbi Clinical course of collagenous colitis over a period of 10 years
    A Madisch
    Medical Department I, University Hospital Dresden
    Z Gastroenterol 44:971-4. 2006
  9. ncbi Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial
    Stephan Miehlke
    Medical Department I, Technical University Hospital, Dresden, Germany
    Gastroenterology 135:1510-6. 2008
  10. ncbi One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin
    Stephan Miehlke
    Medical Department I, Technical University Hospital, Dresden, Germany
    Helicobacter 13:69-74. 2008

Detail Information

Publications17

  1. ncbi Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study
    Károly R Kulich
    AstraZeneca R and D, Medical Science, Molndal, S 431 86, Sweden
    Health Qual Life Outcomes 6:12. 2008
    ....
  2. ncbi Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial
    Ahmed Madisch
    Medical Department I, Technical University Hospital, Fetscherstrasse 74, 01307, Dresden, Germany
    Int J Colorectal Dis 22:1445-51. 2007
    ..The objective of this study was to investigate the effect of Boswellia serrata extract (BSE) on symptoms, quality of life, and histology in patients with collagenous colitis...
  3. ncbi Less favorable clinical outcome after diagnostic and interventional double balloon enteroscopy in patients with suspected small-bowel bleeding?
    A Madisch
    Medical Department I, Technical University Hospital, Dresden, Germany
    Endoscopy 40:731-4. 2008
    ..One of the main indications for DBE is suspected small-bowel bleeding (SSBB). Data about clinical outcome after DBE are limited. The aim of the present study was to prospectively assess the short-term clinical outcome of this procedure...
  4. ncbi NOD2/CARD15 gene polymorphisms are not associated with collagenous colitis
    Ahmed Madisch
    Medical Department I, Technical University Hospital, Fetscherstr 74, D 01307 Dresden, Germany
    Int J Colorectal Dis 22:425-8. 2007
    ..Collagenous colitis is a chronic inflammatory bowel disease of unknown origin. In some cases of collagenous colitis, histomorphological features are comparable to other inflammatory bowel diseases...
  5. ncbi Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial
    A Madisch
    Medical Department I, Technical University Hospital, Dresden, Germany
    Aliment Pharmacol Ther 23:473-9. 2006
    ..An association between Helicobacter pylori infection and lymphocytic gastritis has been postulated...
  6. ncbi Management of functional dyspepsia: Unsolved problems and new perspectives
    Ahmed Madisch
    Medical Department I, Technical University Hospital, Fetscherstrasse 74, D 01307 Dresden, Germany
    World J Gastroenterol 11:6577-81. 2005
    ..A fixed combination of peppermint oil and caraway oil in patients suffering from FD could be proven effective by well-designed clinical trials...
  7. ncbi Investigational treatment options in microscopic colitis
    Ahmed Madisch
    University Hospital, Carl Gustav Carus Dresden, Medical Department I, Fetscherstrasse 74, D 01307 Dresden, Germany
    Expert Opin Investig Drugs 17:1829-37. 2008
    ..Other anti-inflammatory drugs such as mesalazine or bismuth subsalicylate are now under evaluation. The optimal long-term management strategy of microscopic colitis, however, remains an unsolved issue...
  8. ncbi Clinical course of collagenous colitis over a period of 10 years
    A Madisch
    Medical Department I, University Hospital Dresden
    Z Gastroenterol 44:971-4. 2006
    ..The aim of this study was to evaluate the long-term outcome of patients with collagenous colitis 10 years after the diagnosis...
  9. ncbi Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial
    Stephan Miehlke
    Medical Department I, Technical University Hospital, Dresden, Germany
    Gastroenterology 135:1510-6. 2008
    ..Oral budesonide effectively induces clinical remission in patients with collagenous colitis, a debilitating illness characterized by chronic watery/loose diarrhea, but there is a high rate of relapse after treatment cessation...
  10. ncbi One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin
    Stephan Miehlke
    Medical Department I, Technical University Hospital, Dresden, Germany
    Helicobacter 13:69-74. 2008
    ..To investigate a 1-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for rescue therapy of Helicobacter pylori infection...
  11. ncbi Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study
    Stephan Miehlke
    Medical Department I, Technical University Hospital, Dresden, Germany
    Gastroenterology 136:2092-100. 2009
    ..We performed a randomized, double-blind, placebo-controlled study to evaluate the effects of budesonide in patients with lymphocytic colitis...
  12. ncbi Oral budesonide therapy improves quality of life in patients with collagenous colitis
    Ahmed Madisch
    Medical Department I, Technical University Hospital, Fetscherstrasse 74, 01307 Dresden, Germany
    Int J Colorectal Dis 20:312-6. 2005
    ..Six-week treatment with oral budesonide controlled-release capsules significantly improves quality of life and clinical symptoms compared with placebo in these patients...
  13. ncbi Allelic variation of the matrix metalloproteinase-9 gene is associated with collagenous colitis
    Ahmed Madisch
    Medical Department I, Academic Teaching Hospital Siloah, Hannover, Germany
    Inflamm Bowel Dis 17:2295-8. 2011
    ..The aim was to assess genetic polymorphisms of MMP-1, -7, and -9 in a case-control setting for susceptibility to collagenous colitis...
  14. ncbi Resolution of gastrointestinal protein loss after Helicobacter pylori eradication in a patient with hypertrophic lymphocytic gastritis
    Ahmed Madisch
    Medical Department I, Technical University Hospital, Dresden, Germany
    Helicobacter 9:629-31. 2004
    ..Here, we describe a patient with hypertrophic lymphocytic gastritis, in whom gastrointestinal protein loss resolved completely following H. pylori eradication...
  15. ncbi Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation
    Ahmed Madisch
    Medical Department I, Technical University Hospital, Fetscherstr 74, D 01307 Dresden, Germany
    World J Gastroenterol 11:1182-6. 2005
    ..To report the long-term outcome of patients after complete ablation of non-neoplastic Barrett's esophagus (BE) with respect to BE relapse and development of intraepithelial neoplasia or esophageal adenocarcinoma...
  16. ncbi Helicobacter pylori in gastric corpus of patients 20 years after partial gastric resection
    Christian Kirsch
    Medical Department I, Technical University Hospital Carl Gustav Carus, Fetscherstrabe 74, D-01307 Dresden, Germany
    World J Gastroenterol 10:2557-9. 2004
    ..The expression of H pylori gastritis in the gastric remnant does not resemble the gastric cancer phenotype...
  17. ncbi Efficacy of Helicobacter pylori eradication in uninvestigated chronic dyspeptic staff members of a large factory: a prospective, long-term, follow-up, workplace outcome study
    Ahmed Madisch
    Department of Gastroenterology, General Hospital Celle, Germany
    Eur J Gastroenterol Hepatol 14:61-9. 2002
    ..pylori test-and-treat strategy in occupational medicine is effective for improving uninvestigated dyspepsia and quality of life and it may reduce dyspepsia related health care costs at a level of occupational medicine...